Literature DB >> 28785424

The Bi-directional Impact of Two Chronic Illnesses: Heart Failure and Diabetes - A review of the Epidemiology and Outcomes.

Patrick Campbell1, Selim Krim1, Hector Ventura1.   

Abstract

Heart failure and diabetes mellitus contribute significantly to the morbidity and mortality of the US population. The combined economic impact on the US health care system reaches nearly $300 billion. Much of this cost stems from the frequent hospital admissions and direct cost of managing the two diseases. The presence of diabetes significantly increases the risk of developing heart failure compared to the general population and diabetics with heart failure experience significantly higher mortality. Patients with heart failure have a high incidence of insulin resistance and are at increased risk of developing diabetes mellitus. Traditionally these two chronic illnesses have been managed in relative isolation. However the adverse effects of each disease has significant impact on the other. The combination of heart failure and diabetes mellitus significantly increases the morbidity and mortality compared to either in isolation. This paper reviews the epidemiology and impact of the bidirectional effects of these two chronic illnesses.

Entities:  

Keywords:  Heart failure; diabetes mellitus; epidemiology; morbidity; mortality; outcome

Year:  2015        PMID: 28785424      PMCID: PMC5490942          DOI: 10.15420/cfr.2015.01.01.8

Source DB:  PubMed          Journal:  Card Fail Rev        ISSN: 2057-7540


  34 in total

1.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

2.  Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.

Authors:  Satyam Sarma; Robert J Mentz; Mary J Kwasny; Angela J Fought; Mark Huffman; Haris Subacius; Savina Nodari; Marvin Konstam; Karl Swedberg; Aldo P Maggioni; Faiez Zannad; Robert O Bonow; Mihai Gheorghiade
Journal:  Eur J Heart Fail       Date:  2012-10-11       Impact factor: 15.534

Review 3.  Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management.

Authors:  V Baliga; R Sapsford
Journal:  Diab Vasc Dis Res       Date:  2009-07       Impact factor: 3.291

4.  Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.

Authors:  Marcus Lind; Ioannis Bounias; Marita Olsson; Soffia Gudbjörnsdottir; Ann-Marie Svensson; Annika Rosengren
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

5.  Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure.

Authors:  Stephanie Smooke; Tamara B Horwich; Gregg C Fonarow
Journal:  Am Heart J       Date:  2005-01       Impact factor: 4.749

6.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

7.  Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.

Authors:  Sandeep R Das; Mark H Drazner; Clyde W Yancy; Lynne W Stevenson; Bernard J Gersh; Daniel L Dries
Journal:  Am Heart J       Date:  2004-11       Impact factor: 4.749

8.  EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

Authors:  Markku S Nieminen; Dirk Brutsaert; Kenneth Dickstein; Helmut Drexler; Ferenc Follath; Veli-Pekka Harjola; Matthias Hochadel; Michel Komajda; Johan Lassus; Jose Luis Lopez-Sendon; Piotr Ponikowski; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

9.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

10.  Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  Michael R MacDonald; Mark C Petrie; Fumi Varyani; Jan Ostergren; Eric L Michelson; James B Young; Scott D Solomon; Christopher B Granger; Karl Swedberg; Salim Yusuf; Marc A Pfeffer; John J V McMurray
Journal:  Eur Heart J       Date:  2008-04-14       Impact factor: 29.983

View more
  2 in total

1.  Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.

Authors:  Palvinder Kaur; Nakul Saxena; Alex Xiaobin You; Raymond C C Wong; Choon Pin Lim; Seet Yoong Loh; Pradeep Paul George
Journal:  BMJ Open       Date:  2018-05-20       Impact factor: 2.692

2.  Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.

Authors:  Mohammed Al-Jarallah; Rajesh Rajan; Ibrahim Al-Zakwani; Raja Dashti; Bassam Bulbanat; Mustafa Ridha; Kadhim Sulaiman; Alawi A Alsheikh-Ali; Prashanth Panduranga; Khalid F AlHabib; Jassim Al Suwaidi; Wael Al-Mahmeed; Hussam AlFaleh; Abdelfatah Elasfar; Ahmed Al-Motarreb; Nooshin Bazargani; Nidal Asaad; Haitham Amin
Journal:  ESC Heart Fail       Date:  2019-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.